Orchestra BioMed Says First Patient Was Randomized In The BACKBEAT Pivotal Study In Late December 2023
The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications.